-
Je něco špatně v tomto záznamu ?
Differential diagnosis of the small renal masses: role of the apparent diffusion coefficient of the diffusion-weighted MRI
Y. Mytsyk, I. Dutka, B. Yuriy, I. Maksymovych, M. Caprnda, K. Gazdikova, L. Rodrigo, P. Kruzliak, P. Illjuk, AA. Farooqi,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
NLK
ProQuest Central
od 1999-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2011-03-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1999-01-01 do Před 1 rokem
- MeSH
- cystická onemocnění ledvin diagnóza MeSH
- diferenciální diagnóza MeSH
- difuzní magnetická rezonance metody MeSH
- dospělí MeSH
- karcinom z renálních buněk * diagnóza patologie chirurgie MeSH
- léčba šetřící orgány metody MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádory ledvin * diagnóza patologie chirurgie MeSH
- nefrektomie metody MeSH
- reprodukovatelnost výsledků MeSH
- senioři MeSH
- senzitivita a specificita MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
INTRODUCTION: Renal cell carcinoma (RCC) accounts for approximately 3% of adult malignancies and more than 90% of neoplasms arising from the kidney. Uninformative percutaneous kidney biopsies vary from 10 to 23%. As a result, 7.5-33.6% of partial nephrectomies in patients with small renal masses (SRM) are performed on benign renal tumors. The aim of this study was to assess the feasibility of the apparent diffusion coefficient (ADC) of the diffusion-weighted imaging (DWI) of MRI, as RCC imaging biomarker for differentiation of SRM. METHOD: Adult patients (n = 158) with 170 SRM were enrolled into this study. The control group were healthy volunteers with normal clinical and radiologic findings (n = 15). All participants underwent MRI with DWI sequence included. RESULTS: Mean ADC values of solid RCC (1.65 ± 0.38 × 10-3 mm2/s) were lower than healthy renal parenchyma (2.47 ± 0.12 × 10-3 mm2/s, p < 0.05). There was no difference between mean ADC values of ccRCC, pRCC and chRCC (1.82 ± 0.22 × 10-3 vs 1.61 ± 0.07 × 10-3 vs 1.46 ± 0.09 × 10-3 mm2/s, respectively, p = ns). An inverse relationship between mean ADC values and Fuhrman grade of nuclear atypia of solid ccRCCs was observed: grade I-1.92 ± 0.11 × 10-3 mm2/s, grade II-1.84 ± 0.14 × 10-3 mm2/s, grade III-1.79 ± 0.10 × 10-3 mm2/s, grade IV-1.72 ± 0.06 × 10-3 mm2/s. This was significant (p < 0.05) only between tumors of I and IV grades. Significant difference (p < 0.05) between mean ADC values of solid RCCs, benign renal tumors and renal cysts was observed (1.65 ± 0.38 × 10-3 vs 2.23 ± 0.18 × 10-3 vs 3.15 ± 0.51 × 10-3 mm2/s, respectively). In addition, there was a significant difference (p < 0.05) in mean ADC values between benign cysts and cystic RCC (3.36 ± 0.35 × 10-3 vs 2.83 ± 0.21 × 10-3 mm2/s, respectively). CONCLUSION: ADC maps with b values of 0 and 800 s/mm2 can be used as an imaging biomarker, to differentiate benign SRM from malignant SRM. Using ADC value threshold of 1.75 × 10-3 mm2/s allows to differentiate solid RCC from solid benign kidney tumors with 91% sensitivity and 89% specificity; ADC value threshold of 2.96 × 10-3 mm2/s distinguishes cystic RCC from benign renal cysts with 90% sensitivity and 88% specificity. However, the possibility of differentiation between ccRCC histologic subtypes and grades, utilizing ADC values, is limited.
Department of Radiology Lviv National Medical University Lviv Ukraine
Department of Urology Lviv National Medical University Pekarska Str 69 Lviv Ukraine
Euroclinic Medical Center Lviv Ukraine
Faculty of Medicine Central University Hospital of Asturias University of Oviedo Oviedo Spain
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033475
- 003
- CZ-PrNML
- 005
- 20181016112943.0
- 007
- ta
- 008
- 181008s2018 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11255-017-1761-1 $2 doi
- 035 __
- $a (PubMed)29230706
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Mytsyk, Yulian $u Department of Urology, Lviv National Medical University, Pekarska Str. 69, Lviv, Ukraine. mytsyk.yulian@gmail.com.
- 245 10
- $a Differential diagnosis of the small renal masses: role of the apparent diffusion coefficient of the diffusion-weighted MRI / $c Y. Mytsyk, I. Dutka, B. Yuriy, I. Maksymovych, M. Caprnda, K. Gazdikova, L. Rodrigo, P. Kruzliak, P. Illjuk, AA. Farooqi,
- 520 9_
- $a INTRODUCTION: Renal cell carcinoma (RCC) accounts for approximately 3% of adult malignancies and more than 90% of neoplasms arising from the kidney. Uninformative percutaneous kidney biopsies vary from 10 to 23%. As a result, 7.5-33.6% of partial nephrectomies in patients with small renal masses (SRM) are performed on benign renal tumors. The aim of this study was to assess the feasibility of the apparent diffusion coefficient (ADC) of the diffusion-weighted imaging (DWI) of MRI, as RCC imaging biomarker for differentiation of SRM. METHOD: Adult patients (n = 158) with 170 SRM were enrolled into this study. The control group were healthy volunteers with normal clinical and radiologic findings (n = 15). All participants underwent MRI with DWI sequence included. RESULTS: Mean ADC values of solid RCC (1.65 ± 0.38 × 10-3 mm2/s) were lower than healthy renal parenchyma (2.47 ± 0.12 × 10-3 mm2/s, p < 0.05). There was no difference between mean ADC values of ccRCC, pRCC and chRCC (1.82 ± 0.22 × 10-3 vs 1.61 ± 0.07 × 10-3 vs 1.46 ± 0.09 × 10-3 mm2/s, respectively, p = ns). An inverse relationship between mean ADC values and Fuhrman grade of nuclear atypia of solid ccRCCs was observed: grade I-1.92 ± 0.11 × 10-3 mm2/s, grade II-1.84 ± 0.14 × 10-3 mm2/s, grade III-1.79 ± 0.10 × 10-3 mm2/s, grade IV-1.72 ± 0.06 × 10-3 mm2/s. This was significant (p < 0.05) only between tumors of I and IV grades. Significant difference (p < 0.05) between mean ADC values of solid RCCs, benign renal tumors and renal cysts was observed (1.65 ± 0.38 × 10-3 vs 2.23 ± 0.18 × 10-3 vs 3.15 ± 0.51 × 10-3 mm2/s, respectively). In addition, there was a significant difference (p < 0.05) in mean ADC values between benign cysts and cystic RCC (3.36 ± 0.35 × 10-3 vs 2.83 ± 0.21 × 10-3 mm2/s, respectively). CONCLUSION: ADC maps with b values of 0 and 800 s/mm2 can be used as an imaging biomarker, to differentiate benign SRM from malignant SRM. Using ADC value threshold of 1.75 × 10-3 mm2/s allows to differentiate solid RCC from solid benign kidney tumors with 91% sensitivity and 89% specificity; ADC value threshold of 2.96 × 10-3 mm2/s distinguishes cystic RCC from benign renal cysts with 90% sensitivity and 88% specificity. However, the possibility of differentiation between ccRCC histologic subtypes and grades, utilizing ADC values, is limited.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a karcinom z renálních buněk $x diagnóza $x patologie $x chirurgie $7 D002292
- 650 _2
- $a diferenciální diagnóza $7 D003937
- 650 _2
- $a difuzní magnetická rezonance $x metody $7 D038524
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a cystická onemocnění ledvin $x diagnóza $7 D052177
- 650 12
- $a nádory ledvin $x diagnóza $x patologie $x chirurgie $7 D007680
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a nefrektomie $x metody $7 D009392
- 650 _2
- $a léčba šetřící orgány $x metody $7 D059351
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 650 _2
- $a senzitivita a specificita $7 D012680
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Dutka, Ihor $u Euroclinic Medical Center, Lviv, Ukraine.
- 700 1_
- $a Yuriy, Borys $u Department of Urology, Lviv National Medical University, Pekarska Str. 69, Lviv, Ukraine.
- 700 1_
- $a Maksymovych, Iryna $u Department of Radiology, Lviv National Medical University, Lviv, Ukraine.
- 700 1_
- $a Caprnda, Martin $u 1st Department of Internal Medicine, Faculty of Medicine, Comenius University and University Hospital, Bratislava, Slovak Republic.
- 700 1_
- $a Gazdikova, Katarina $u Department of Nutrition, Faculty of Nursing and Professional Health Studies, Slovak Medical University, Limbova 12, 833 03, Bratislava, Slovak Republic. katarina.gazdikova@szu.sk. Department of General Medicine, Faculty of Medicine, Slovak Medical University, Bratislava, Slovak Republic. katarina.gazdikova@szu.sk.
- 700 1_
- $a Rodrigo, Luis $u Faculty of Medicine, Central University Hospital of Asturias (HUCA), University of Oviedo, Oviedo, Spain.
- 700 1_
- $a Kruzliak, Peter $u 2nd Department of Surgery, Faculty of Medicine, St. Anne's University Hospital, Masaryk University, Brno, Czech Republic. kruzliakpeter@gmail.com. Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho Tr. 1/1946, 612 42, Brno, Czech Republic. kruzliakpeter@gmail.com.
- 700 1_
- $a Illjuk, Polina $u Department of Radiology, Lviv National Medical University, Lviv, Ukraine.
- 700 1_
- $a Farooqi, Ammad Ahmad $u Laboratory for Translational Oncology and Personalized Medicine, Rashid Latif Medical College, Lahore, Pakistan.
- 773 0_
- $w MED00002396 $t International urology and nephrology $x 1573-2584 $g Roč. 50, č. 2 (2018), s. 197-204
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29230706 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20181016113440 $b ABA008
- 999 __
- $a ok $b bmc $g 1339469 $s 1030469
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 50 $c 2 $d 197-204 $e 20171211 $i 1573-2584 $m International urology and nephrology $n Int Urol Nephrol $x MED00002396
- LZP __
- $a Pubmed-20181008